81 FR 66666 - The National Heart, Lung, and Blood Institute (NHLBI) COPD National Action Plan; Request for Public Comments

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 188 (September 28, 2016)

Page Range		66666-66667
FR Document		2016-23392

NHLBI, with input from federal and nonfederal partners, is developing the COPD National Action Plan to help guide stakeholders nationwide in their efforts to reduce the burden of Chronic Obstructive Pulmonary Disease (COPD). The purpose of this notice is to seek public input on the current draft of the COPD National Action Plan.

Federal Register, Volume 81 Issue 188 (Wednesday, September 28, 2016)

[Federal Register Volume 81, Number 188 (Wednesday, September 28, 2016)]
[Notices]
[Pages 66666-66667]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-23392]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


The National Heart, Lung, and Blood Institute (NHLBI) COPD 
National Action Plan; Request for Public Comments

SUMMARY: NHLBI, with input from federal and nonfederal partners, is 
developing the COPD National Action Plan to help guide stakeholders 
nationwide in their efforts to reduce the burden of Chronic Obstructive 
Pulmonary Disease (COPD). The purpose of this notice is to seek public 
input on the current draft of the COPD National Action Plan.

DATES: To ensure consideration, your responses must be received by 
Friday, October 28, 2016.

ADDRESSES: Responses to this Notice must be submitted electronically 
using either the web-based format at http://www.nhlbi.nih.gov/health/educational/copd/get-involved/town-hall.htm or email to 
[email protected].

FOR FURTHER INFORMATION CONTACT: Lenora E. Johnson, DrPH; Director, 
Office of Science Policy, Engagement, Education, and Communications; 
National Heart, Lung, and Blood Institute; 9000 Rockville Pike, Bldg. 
31, MSC 2480, Bethesda, MD 20892-2480, Telephone: 301-496-4236, Fax: 
301-402-2405.

SUPPLEMENTARY INFORMATION:

Background

    The NHLBI--part of the National Institutes of Health (NIH)--plans, 
conducts, and supports research related to the causes, prevention, 
diagnosis, and treatment of heart, blood vessel, lung, and blood 
diseases; and sleep disorders. The NHLBI is the NIH institute with 
primary responsibility for portfolio of research related to lung 
diseases.
    The NHLBI provides global leadership for research, training, and 
education programs to promote the prevention and treatment of heart, 
lung, and blood diseases and enhance the health of all individuals so 
that they can live longer and more fulfilling lives. The Institute

[[Page 66667]]

also administers national health education campaigns on COPD, women and 
heart disease, healthy weight for children, and other topics. NHLBI 
press releases and other materials are available online at 
www.nhlbi.nih.gov.
    The importance of COPD as a public health issue was highlighted by 
the Senate Appropriations Committee in fiscal year 2012 with its charge 
to the NHLBI ``to work with community stakeholders and other federal 
agencies, including the Centers for Disease Control and Prevention 
(CDC), to develop a national action plan to respond to the growing 
burden of this disease.'' A letter from Reps. John Lewis, Dave Joyce 
and Carol Shea-Porter in November 2014 to Dr. Thomas Frieden, Director 
of the CDC, and Dr. Francis Collins, Director of the NIH, requested 
``that the NIH and the CDC create a National Action Plan for COPD in 
fiscal year 2015.''
    In response to these requests and in collaboration with CDC and 
other federal partners, the NHLBI organized several trans-governmental 
preparatory workshops to discuss the development of such a plan. These 
workshops informed the establishment of six initial core goals to be 
addressed by the COPD National Action Plan.
    In early 2016, the NHLBI hosted a COPD Town Hall Meeting with both 
federal and nonfederal stakeholders, including patients and their 
families. During the two-day meeting, attendees were invited to join 
one of six working groups, each charged with developing objectives, 
strategies, and benchmarks for a specified goal. The recommendations 
made by the working groups directly informed the development of the 
full draft of the COPD National Action Plan that is now available for 
public input.
    Following the public comment period, the NHLBI will incorporate the 
feedback, finalize the COPD National Action Plan, and post the document 
for the public via the NHLBI Web site.

Information Requested

    This notice invites public comment on the draft COPD National 
Action Plan draft. We ask that the public review the draft and provide 
feedback on its content, strategies, and tactics, as well as the 
opportunities it suggests organizations consider to help reduce the 
burden of COPD.
    Input is being sought on each of the areas identified below, and 
respondents can provide comment to select areas or all of them.
    (1) Goal 1: Empower people with COPD, their families, and 
caregivers to recognize and reduce the burden of COPD.
    (2) Goal 2: Improve the prevention, diagnosis, treatment, and 
management of COPD by promoting and sustaining the education and 
training of health care professionals.
    (3) Goal 3: Collect, analyze, disseminate, and report COPD-related 
public health data that drives change and tracks progress.
    (4) Goal 4: Increase and sustain research to better understand 
prevention, pathogenesis, diagnosis, treatment, and management of COPD.
    (5) Goal 5: Translate national policy, education, and program 
recommendations into legislative, research, and public health care 
actions.
    (6) Additional comments, information, or suggestions about 
organizations that should be part of the COPD National Action Plan 
implementation.

General Information

    All of the fields in the response are optional and voluntary. Any 
personal identifiers will be removed when responses are compiled. 
Proprietary, classified, confidential, or sensitive information should 
not be included in your response. This notice is for planning purposes 
only and is not a solicitation for applications or an obligation on the 
part of the United States (U.S.) government to provide support for any 
ideas identified in response to it. Please note that the U.S. 
government will not pay for the preparation of any comment submitted or 
for its use of that comment.
    Please provide your name and email address so that we can follow up 
with you should we have any questions regarding your submission. If you 
are a member of a particular advocacy or professional organization, 
please indicate the name and primary focus of the organization (i.e., 
research support, patient care, etc.) and whether you are responding on 
behalf of your organization. If you are not, please indicate your 
position within the organization.
    Privacy Act Notification Statement: We are requesting your comments 
on the draft COPD National Action Plan. The information you provide may 
be disclosed to NHLBI staff and contractors working on our behalf. 
Submission of this information is voluntary. However, the information 
you provide will help us develop a more complete COPD National Action 
Plan. Additionally, contact details will allow us to follow up with you 
should there be any questions to your feedback.
    Collection of this information is authorized under 42 U.S.C. 203, 
24 1, 2891-1 and 44 U.S.C. 310 I and Section 30 l and 493 of the Public 
Health Service Act regarding the establishment of the National 
Institutes of Health, its general authority to conduct and fund 
research and to provide training assistance, and its general authority 
to maintain records in connection with these and its other functions.

    Dated: September 21, 2016.
Gary H. Gibbons,
Director, National Heart, Lung, and Blood Institute, National 
Institutes of Health.
[FR Doc. 2016-23392 Filed 9-27-16; 8:45 am]
BILLING CODE 4140-01-P

66666 Federal Register / Vol. 81, No. 188 / Wednesday, September 28, 2016 / Notices

amended (5 U.S.C. App.), notice is amended (5 U.S.C. App.), notice is Research; 93.849, Kidney Diseases, Urology
hereby given of the following meetings. hereby given of the following meetings. and Hematology Research, National Institutes
The meetings will be closed to the of Health, HHS)
The meetings will be closed to the
public in accordance with the public in accordance with the Dated: September 22, 2016.
provisions set forth in sections provisions set forth in sections David Clary,
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Program Analyst, Office of Federal Advisory
as amended. The grant applications and as amended. The grant applications and Committee Policy.
the discussions could disclose the discussions could disclose [FR Doc. 2016–23315 Filed 9–27–16; 8:45 am]
confidential trade secrets or commercial confidential trade secrets or commercial BILLING CODE 4140–01–P
property such as patentable material, property such as patentable material,
and personal information concerning and personal information concerning
individuals associated with the grant individuals associated with the grant DEPARTMENT OF HEALTH AND
applications, the disclosure of which applications, the disclosure of which HUMAN SERVICES
would constitute a clearly unwarranted would constitute a clearly unwarranted
invasion of personal privacy. invasion of personal privacy. National Institutes of Health
Name of Committee: National Institute of Name of Committee: National Institute of
The National Heart, Lung, and Blood
Biomedical Imaging and Bioengineering Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK Ancillary Institute (NHLBI) COPD National Action
Special Emphasis Panel; P41 BTRC review Plan; Request for Public Comments
(2017/01). Studies.
Date: November 17, 2016.
Date: November 17, 2016. SUMMARY: NHLBI, with input from
Time: 08:00 a.m. to 7:00 p.m. Time: 11:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant federal and nonfederal partners, is
Agenda: To review and evaluate grant developing the COPD National Action
applications. applications.
Place: National Institutes of Health, Two Plan to help guide stakeholders
Place: National Institutes of Health, Two
Democracy Plaza, Suite 920, 6707 Democracy Democracy Plaza, 6707 Democracy nationwide in their efforts to reduce the
Boulevard, Bethesda, MD 20892, (Virtual Boulevard, Bethesda, MD 20892, (Telephone burden of Chronic Obstructive
Meeting). Conference Call). Pulmonary Disease (COPD). The
Contact Person: Dennis Hlasta, Ph.D., Contact Person: Elena Sanovich, Ph.D., purpose of this notice is to seek public
Scientific Review Officer, National Institute Scientific Review Officer, Review Branch, input on the current draft of the COPD
DEA, NIDDK, National Institutes of Health,
of Biomedical Imaging and Bioengineering, National Action Plan.
National Institutes of Health, 6707 Room 7351, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, 301–594–8886, DATES: To ensure consideration, your
Democracy Blvd., Bethesda, MD 20892, (301)
451–4794, dennis.hlasta@nih.gov. sanoviche@mail.nih.gov. responses must be received by Friday,
Name of Committee: National Institute of October 28, 2016.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering Diabetes and Digestive and Kidney Diseases ADDRESSES: Responses to this Notice
Special Emphasis Panel; R13 Review (2017/ Special Emphasis Panel; Improving Diabetes must be submitted electronically using
01). Management in Children with Type 1 either the web-based format at http://
Date: December 6, 2016. Diabetes (DP3). www.nhlbi.nih.gov/health/educational/
Time: 12:00 p.m. to 4:00 p.m. Date: November 17, 2016.
Time: 2:00 p.m. to 4:00 p.m.
copd/get-involved/town-hall.htm or
Agenda: To review and evaluate grant email to COPDActionPlan@
applications. Agenda: To review and evaluate grant
applications. porternovelli.com.
Place: National Institutes of Health, Two
Democracy Plaza, Suite 920, 6707 Democracy Place: National Institutes of Health, Two FOR FURTHER INFORMATION CONTACT:
Boulevard, Bethesda, MD 20892, (Telephone Democracy Plaza, 6707 Democracy Lenora E. Johnson, DrPH; Director,
Conference Call). Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Office of Science Policy, Engagement,
Contact Person: Manana Sukhareva, Ph.D., Education, and Communications;
Scientific Review Officer, National Institute Contact Person: Paul A. Rushing, Ph.D.,
Scientific Review Officer, Review Branch, National Heart, Lung, and Blood
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707 DEA, NIDDK, National Institutes of Health, Institute; 9000 Rockville Pike, Bldg. 31,
Democracy Blvd., Suite 959, Bethesda, MD Room 7345, 6707 Democracy Boulevard, MSC 2480, Bethesda, MD 20892–2480,
20892, (301) 451–3397, sukharem@ Bethesda, MD 20892–5452, (301) 594–8895, Telephone: 301–496–4236, Fax: 301–
mail.nih.gov. rushingp@extra.niddk.nih.gov. 402–2405.
Name of Committee: National Institute of SUPPLEMENTARY INFORMATION:
Dated: September 21, 2016. Diabetes and Digestive and Kidney Diseases
David Clary, Special Emphasis Panel; Digestive Diseases Background
Program Analyst, Office of Federal Advisory Centers.
Committee Policy. Date: November 17–18, 2016. The NHLBI—part of the National
Time: 6:00 p.m. to 6:00 p.m. Institutes of Health (NIH)—plans,
[FR Doc. 2016–23313 Filed 9–27–16; 8:45 am]
Agenda: To review and evaluate grant conducts, and supports research related
BILLING CODE 4140–01–P
applications. to the causes, prevention, diagnosis, and
Place: Bethesda North Marriott Hotel, treatment of heart, blood vessel, lung,
Conference Center, 5701 Marinelli Road, and blood diseases; and sleep disorders.
DEPARTMENT OF HEALTH AND Bethesda, MD 20852. The NHLBI is the NIH institute with
HUMAN SERVICES Contact Person: Maria E. Davila-Bloom, primary responsibility for portfolio of
Ph.D., Scientific Review Officer, Review research related to lung diseases.
mstockstill on DSK3G9T082PROD with NOTICES

National Institutes of Health Branch, DEA, NIDDK, Room 7017, 6707
Democracy Boulevard, Bethesda, MD 20892,
The NHLBI provides global leadership
National Institute of Diabetes and (301) 594–7637, davila-bloomm@ for research, training, and education
Digestive and Kidney Diseases; Notice extra.niddk.nih.gov. programs to promote the prevention and
of Closed Meetings (Catalogue of Federal Domestic Assistance treatment of heart, lung, and blood
Program Nos. 93.847, Diabetes, diseases and enhance the health of all
Pursuant to section 10(d) of the Endocrinology and Metabolic Research; individuals so that they can live longer
Federal Advisory Committee Act, as 93.848, Digestive Diseases and Nutrition and more fulfilling lives. The Institute

VerDate Sep<11>2014 18:04 Sep 27, 2016 Jkt 238001 PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 E:\FR\FM\28SEN1.SGM 28SEN1

Federal Register / Vol. 81, No. 188 / Wednesday, September 28, 2016 / Notices 66667

also administers national health recognize and reduce the burden of Collection of this information is
education campaigns on COPD, women COPD. authorized under 42 U.S.C. 203, 24 1,
and heart disease, healthy weight for (2) Goal 2: Improve the prevention, 2891–1 and 44 U.S.C. 310 I and Section
children, and other topics. NHLBI press diagnosis, treatment, and management 30 l and 493 of the Public Health
releases and other materials are of COPD by promoting and sustaining Service Act regarding the establishment
available online at www.nhlbi.nih.gov. the education and training of health care of the National Institutes of Health, its
The importance of COPD as a public professionals. general authority to conduct and fund
health issue was highlighted by the (3) Goal 3: Collect, analyze, research and to provide training
Senate Appropriations Committee in disseminate, and report COPD-related assistance, and its general authority to
fiscal year 2012 with its charge to the public health data that drives change maintain records in connection with
NHLBI ‘‘to work with community and tracks progress. these and its other functions.
stakeholders and other federal agencies, (4) Goal 4: Increase and sustain Dated: September 21, 2016.
including the Centers for Disease research to better understand Gary H. Gibbons,
Control and Prevention (CDC), to prevention, pathogenesis, diagnosis, Director, National Heart, Lung, and Blood
develop a national action plan to treatment, and management of COPD. Institute, National Institutes of Health.
respond to the growing burden of this (5) Goal 5: Translate national policy, [FR Doc. 2016–23392 Filed 9–27–16; 8:45 am]
disease.’’ A letter from Reps. John education, and program BILLING CODE 4140–01–P
Lewis, Dave Joyce and Carol Shea-Porter recommendations into legislative,
in November 2014 to Dr. Thomas research, and public health care actions.
Frieden, Director of the CDC, and Dr. (6) Additional comments, DEPARTMENT OF HEALTH AND
Francis Collins, Director of the NIH, information, or suggestions about HUMAN SERVICES
requested ‘‘that the NIH and the CDC organizations that should be part of the
create a National Action Plan for COPD COPD National Action Plan National Institutes of Health
in fiscal year 2015.’’ implementation.
In response to these requests and in National Center for Advancing
collaboration with CDC and other General Information Translational Sciences; Notice of
federal partners, the NHLBI organized All of the fields in the response are Closed Meeting
several trans-governmental preparatory optional and voluntary. Any personal
workshops to discuss the development identifiers will be removed when Pursuant to section 10(d) of the
of such a plan. These workshops responses are compiled. Proprietary, Federal Advisory Committee Act, as
informed the establishment of six initial classified, confidential, or sensitive amended (5 U.S.C. App.), notice is
core goals to be addressed by the COPD information should not be included in hereby given of the following meeting.
National Action Plan. your response. This notice is for The meeting will be closed to the
In early 2016, the NHLBI hosted a planning purposes only and is not a public in accordance with the
COPD Town Hall Meeting with both solicitation for applications or an provisions set forth in sections
federal and nonfederal stakeholders, obligation on the part of the United 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
including patients and their families. States (U.S.) government to provide as amended. The grant applications and
During the two-day meeting, attendees support for any ideas identified in the discussions could disclose
were invited to join one of six working response to it. Please note that the U.S. confidential trade secrets or commercial
groups, each charged with developing government will not pay for the property such as patentable material,
objectives, strategies, and benchmarks preparation of any comment submitted and personal information concerning
for a specified goal. The or for its use of that comment. individuals associated with the grant
recommendations made by the working Please provide your name and email applications, the disclosure of which
groups directly informed the address so that we can follow up with would constitute a clearly unwarranted
development of the full draft of the you should we have any questions invasion of personal privacy.
COPD National Action Plan that is now regarding your submission. If you are a Name of Committee: National Center for
available for public input. member of a particular advocacy or Advancing Translational Sciences Special
Following the public comment professional organization, please Emphasis Panel; R21 Innovation Awards.
period, the NHLBI will incorporate the indicate the name and primary focus of Date: October 24, 2016.
feedback, finalize the COPD National the organization (i.e., research support, Time: 2:00 p.m. to 3:30 p.m.
Action Plan, and post the document for patient care, etc.) and whether you are Agenda: To review and evaluate grant
the public via the NHLBI Web site. responding on behalf of your applications.
Place: National Institutes of Health, 6701
organization. If you are not, please Democracy Boulevard, Room 1037, Bethesda,
Information Requested
indicate your position within the MD 20892.
This notice invites public comment organization. Contact Person: Christine A. Livingston,
on the draft COPD National Action Plan Privacy Act Notification Statement: Ph.D., Scientific Review Officer, Office of
draft. We ask that the public review the We are requesting your comments on Scientific Review, National Center for
draft and provide feedback on its the draft COPD National Action Plan. Advancing Translational Sciences (NCATS),
content, strategies, and tactics, as well The information you provide may be National Institutes of Health, 6701
as the opportunities it suggests disclosed to NHLBI staff and contractors Democracy Blvd., Democracy 1, Room 1073,
organizations consider to help reduce working on our behalf. Submission of Bethesda, MD 20892, (301) 435–1348,
mstockstill on DSK3G9T082PROD with NOTICES

livingsc@mail.nih.gov.
the burden of COPD. this information is voluntary. However,
Input is being sought on each of the the information you provide will help (Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
areas identified below, and respondents us develop a more complete COPD Physiology, and Biological Chemistry
can provide comment to select areas or National Action Plan. Additionally, Research; 93.350, B—Cooperative
all of them. contact details will allow us to follow Agreements; 93.859, Biomedical Research
(1) Goal 1: Empower people with up with you should there be any and Research Training, National Institutes of
COPD, their families, and caregivers to questions to your feedback. Health, HHS)

VerDate Sep<11>2014 18:04 Sep 27, 2016 Jkt 238001 PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 E:\FR\FM\28SEN1.SGM 28SEN1

Document Created: 2016-09-28 01:08:51
Document Modified: 2016-09-28 01:08:51

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		To ensure consideration, your responses must be received by Friday, October 28, 2016.
Contact		Lenora E. Johnson, DrPH; Director, Office of Science Policy, Engagement, Education, and Communications; National Heart, Lung, and Blood Institute; 9000 Rockville Pike, Bldg. 31, MSC 2480, Bethesda, MD 20892-2480, Telephone: 301-496-4236, Fax: 301-402-2405.
FR Citation		81 FR 66666

81 FR 66666 - The National Heart, Lung, and Blood Institute (NHLBI) COPD National Action Plan; Request for Public Comments

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 188 (September 28, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health